Meet us at the World Orphan Drug Congress 2024

Boston Convention and Exhibition Center

23-25 April

We’re delighted to confirm our attendance at the World Orphan Drug Congress 2024 in Boston, USA.

Join us and discover an end-to-end commercialisation partner for your rare and orphan medicines abroad.

Meet our team at the WODC 2024

Don’t hesitate to request a meeting using the form below. According to your needs, we will arrange availability for our SMEs to discuss your challenges and best strategies to access Europe.

Select the area of interest:(Required)

Early Access Programs

Real World Data & Evidence generation

Patient Support Programs

Supply Chain Management

Regulatory Support

Commercialization

End-to-end solution

Your Name(Required)

First Last

Your Email Address(Required)

Your Company(Required)

Job Title(Required)

Any questions?

Please let us know what’s on your mind. Have a question for us? Ask away.

Comments

This field is for validation purposes and should be left unchanged.

Meet our experts

Andrew Cummins

Director of Expanded Access Programs

Andrew Cummins is our Director of Expanded Access Programs. Speak to him about the best regulatory pathways that enable you to widen potentially lifesaving access to investigational and pre-approval medication.

Gilbert Frishert

Director of Logistics

Gilbert Frishert is our Director of Logistics. Speak to him about overcoming the complex challenges of setting up and running an effective supply chain for rare and orphan drugs.

Mathieu Loiseau

Head of Rare Diseases Clinical Operations

Mathieu Loiseau is the Head of Rare Diseases Clinical Operations at Sciensus. Speak to him about how we can support your rare and orphan drugs in market, improving patient adherence and health outcomes.